Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Heart Failure
Search: search_blue_button Advanced Search
Published Online
on April 14, 2009

Circulation: Heart Failure. 2009
Published online before print April 14, 2009, doi: 10.1161/CIRCHEARTFAILURE.108.822999
A more recent version of this article appeared on May 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2/3/181    most recent
CIRCHEARTFAILURE.108.822999v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palardy, M.
Right arrow Articles by Reimold, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palardy, M.
Right arrow Articles by Reimold, S. C.
Related Collections
Right arrow Other heart failure
Right arrow Congestive
Right arrow Myocardial cardiomyopathy disease
Right arrow Valvular heart disease
Right arrow Catheter-based coronary and valvular interventions: other

Original Article

Reduction in Mitral Regurgitation During Therapy Guided by Measured Filling Pressures in the ESCAPE Trial

Maryse Palardy1; Lynne Warner Stevenson1,9; Gudaye Tasissa2; Michele A. Hamilton3; Robert C. Bourge4; Thomas G. DiSalvo5; Uri Elkayam6; James A. Hill7 and Sharon C. Reimold8

1 Brigham and Women's Hospital, Boston, MA;
2 Duke Medical Center, Durham, NC;
3 UCLA Medical Center, Los Angeles, CA;
4 University of Alabama, Birmingham, AL;
5 Vanderbilt University Hospital, Nashville, TN;
6 University of Southern California, Los Angeles, CA;
7 University of Florida, Gainesville, FL;
8 UT Southwestern Medical Center, Dallas, TX

9 E-mail: lstevenson{at}partners.org

Background—Dynamic mitral regurgitation (MR) contributes to decompensation in chronic dilated heart failure. Reduction of MR was the primary physiologic endpoint in the ESCAPE trial, which compared acute therapy guided by JVP, edema, and weight (CLIN) to therapy guided additionally by pulmonary artery catheters (PAC) toward pulmonary wedge pressure ≤15 and right atrial pressure ≤8 mmHg.

Methods and Results—Patients were randomized to PAC or CLIN during hospitalization with chronic HF and mean LVEF 20%, and at least 1 symptom and 1 sign of congestion. MR and mitral flow patterns, measured blinded to therapy and timepoint, were available at baseline and discharge in 133 patients, and at 3 months in 104 patients. Changes in MR and related transmitral flow patterns were compared between PAC and CLIN patients. Jugular venous pressure, edema, and weights decreased similarly during therapy in the hospital for both groups. In PAC but not in CLIN patients, MR jet area, MR/LAA ratio, and E velocity were each significantly reduced and deceleration time increased by discharge. By 3 months, patients had clinical evidence of increased JVP, edema, and weight since discharge, reaching significance in the PAC arm, and the change in MR was no longer different between the 2 groups, although the change in E velocity remained greater in PAC patients.

Conclusions—During hospitalization, therapy guided by PAC to reduce left-sided pressures improved MR and related filling patterns more than therapy guided clinically by evidence of systemic venous congestion. This early reduction did not translate into improved outcomes out of the hospital, where volume status reverted toward baseline.

Key Words: cardiomyopathy • heart failure • hemodynamics • mitral valve • regurgitation